Chronic Fatigue Etiology in Intensive Care Unit Survivors: the Role of Neuromuscular Function

NCT ID: NCT03849326

Last Updated: 2023-04-26

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

WITHDRAWN

Clinical Phase

NA

Study Classification

INTERVENTIONAL

Study Start Date

2023-12-31

Study Completion Date

2025-04-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Chronic fatigue is the most common and debilitating symptom in intensive care unit (ICU) survivors. Indeed, it has been widely reported that patients who stayed in ICU for prolonged periods report a feeling of tiredness for months to years after ICU discharge. This chronic fatigue affects their quality of life by decreasing their capacity to perform simple tasks of daily life.

The aim of the present project is to determine whether deteriorated neuromuscular function (i.e. increased fatigability) is involved in this feeling of chronic fatigue. Because the causes of this feeling are multi-dimensional, a large battery of tests will allow us to better understand the origin of chronic fatigue. A better knowledge of chronic fatigue etiology will allow to optimize rehabilitation treatments to decrease the apparition/persistence of chronic fatigue and in fine improve life quality.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Chronic Fatigue Syndrome Intensive Care Unit Muscle

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

DIAGNOSTIC

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

"Non-fatigued" patients

Group Type EXPERIMENTAL

Questionnaires

Intervention Type OTHER

Quality of life Depression Physical pain Social provisions Quality of sleep

blood test

Intervention Type BIOLOGICAL

complete blood count and cytokine concentration

Maximal effort test

Intervention Type OTHER

The maximal effort test with VO2max recordings will be assessed during the first visit to the laboratory.

actigraphy

Intervention Type DEVICE

assessment of sleep quality

Neuromuscular evaluation

Intervention Type DEVICE

* The maximum isometric force produced by the knee extensors will be measured on the ergometer
* the intensity of muscular electrical activity recorded by surface electromyography
* Peripheral nerve stimulation
* Transcranial magnetic stimulation
* Magnetic resonance imaging (optional)

"Fatigued" patients

Group Type EXPERIMENTAL

Questionnaires

Intervention Type OTHER

Quality of life Depression Physical pain Social provisions Quality of sleep

blood test

Intervention Type BIOLOGICAL

complete blood count and cytokine concentration

Maximal effort test

Intervention Type OTHER

The maximal effort test with VO2max recordings will be assessed during the first visit to the laboratory.

actigraphy

Intervention Type DEVICE

assessment of sleep quality

Neuromuscular evaluation

Intervention Type DEVICE

* The maximum isometric force produced by the knee extensors will be measured on the ergometer
* the intensity of muscular electrical activity recorded by surface electromyography
* Peripheral nerve stimulation
* Transcranial magnetic stimulation
* Magnetic resonance imaging (optional)

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Questionnaires

Quality of life Depression Physical pain Social provisions Quality of sleep

Intervention Type OTHER

blood test

complete blood count and cytokine concentration

Intervention Type BIOLOGICAL

Maximal effort test

The maximal effort test with VO2max recordings will be assessed during the first visit to the laboratory.

Intervention Type OTHER

actigraphy

assessment of sleep quality

Intervention Type DEVICE

Neuromuscular evaluation

* The maximum isometric force produced by the knee extensors will be measured on the ergometer
* the intensity of muscular electrical activity recorded by surface electromyography
* Peripheral nerve stimulation
* Transcranial magnetic stimulation
* Magnetic resonance imaging (optional)

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Have been ventilated for at least 72 hours in the intensive care unit
* IGS2 score (severity in resuscitation) \> 15
* FACIT-F (Functional Assessment of Chronic Illness Therapy-Fatigue) score ≥ 36 or a score ≤ 32
* intensive care unit discharge in ≥ 6 months and ≤ 5 years preceding the study
* Approval received from a physician
* Command of the French language

Exclusion Criteria

* Taking neuroactive substances that can alter corticospinal excitability
* Contraindication to the application of a magnetic field
* Contraindication to the practice of Magnetic Resonance Imaging
* Participant is pregnant
* Patients with psychiatric disorders
* Paraplegic and hemiplegic patients
* Addictive disorders
Minimum Eligible Age

18 Years

Maximum Eligible Age

75 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Saint-Etienne

UNKNOWN

Sponsor Role collaborator

Centre Hospitalier Universitaire de Saint Etienne

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Jérome MOREL, MD PhD

Role: PRINCIPAL_INVESTIGATOR

CHU de Saint Etienne

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Hôpital privé de la Loire

Saint-Etienne, , France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2018-A03511-54

Identifier Type: OTHER

Identifier Source: secondary_id

18CH175

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Frailty in Critical Care Unit's Patients
NCT06117462 NOT_YET_RECRUITING
MICU Recovery Clinic
NCT02560129 COMPLETED